tiprankstipranks
RepliCel Life Sciences Inc (REPCF)
OTHER OTC:REPCF

RepliCel Life Sciences (REPCF) Financial Statements

22 Followers

RepliCel Life Sciences Financial Overview

RepliCel Life Sciences's market cap is currently ―. The company's EPS TTM is $0.004; its P/E ratio is 8.75; RepliCel Life Sciences is scheduled to report earnings on April 30, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total RevenueC$ 88.43KC$ 88.43KC$ 88.43KC$ -88.43K-
Gross ProfitC$ 88.43KC$ 88.43KC$ 88.43KC$ -88.43K-
EBITC$ -385.78KC$ -558.51KC$ -963.37KC$ -1.06MC$ -1.29M
EBITDAC$ -385.78KC$ -539.62KC$ -954.43KC$ -1.05M-
Net Income Common StockholdersC$ -818.60KC$ -558.51KC$ -963.37KC$ -1.06MC$ -1.29M
Balance Sheet-
Cash Cash Equivalents And Short Term InvestmentsC$ 32.48KC$ 232.77KC$ 697.26KC$ 430.27KC$ 95.31K
Total AssetsC$ 331.46KC$ 495.65KC$ 1.08MC$ 798.22KC$ 456.61K
Total DebtC$ 40.96KC$ 40.96KC$ 40.96KC$ 40.96KC$ 39.15K
Net DebtC$ 8.48KC$ -191.81KC$ -656.31KC$ -389.32KC$ -56.16K
Total LiabilitiesC$ 6.97MC$ 6.55MC$ 6.55MC$ 6.71MC$ 9.24M
Stockholders EquityC$ -6.64MC$ -6.05MC$ -5.47MC$ -5.92MC$ -8.78M
Cash Flow-
Free Cash Flow-C$ -1.55MC$ -1.12MC$ -1.35MC$ -1.17M
Operating Cash Flow-C$ -1.55MC$ -1.12MC$ -1.35MC$ -1.17M
Investing Cash Flow-----
Financing Cash Flow-C$ 1.35MC$ 1.40MC$ 1.67MC$ 1.03M
Currency in CAD

RepliCel Life Sciences Earnings and Revenue History

RepliCel Life Sciences Debt to Assets

RepliCel Life Sciences Cash Flow

RepliCel Life Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis